Biotech and Pharmaceuticals Pharmaceuticals

More

  • GlaxoSmithKline's New Ally For Alli Friday, 20 Mar 2009 | 11:28 AM ET
    alli_logo.jpg

    Normally, the folks at GlaxoSmithKline keep us tightly in the loop when there's news. So, I'm a bit surprised that it took a "tweet" on Twitter this morning to learn that four days ago the company put out a press release that has "Pharma's Market" written all over it.

  • Pfizer: Turning The Bad Economy Into Good PR? Thursday, 19 Mar 2009 | 11:01 AM ET
    Pfizer

    Pfizer announced this morning that it's raising the income levels for uninsured people to qualify for cheaper or free drugs because of the bad economy.

  • How to Get Prescription Drugs for Less Wednesday, 18 Mar 2009 | 5:46 PM ET

    Overpaying for our prescription drugs just feels like a headache no one needs right now, doesn’t it?

  • NEJM Gets At Heart Of Pfizer's/Pharma's Problems Wednesday, 18 Mar 2009 | 5:15 PM ET

    Scientific and medical journals like to keep their distance from the business side of things. That's why I think it's worth noting that a "Perspective" piece--think of it as kind of a newspaper Op-Ed--in "The New England Journal of Medicine" starts by mentioning Pfizer's stock price and its recent proposed acquisition of Wyeth.

  • Sam Waksal Wants Back In Biotech Tuesday, 17 Mar 2009 | 10:55 AM ET
    Sam Waksal

    Despite my repeated invitations for his first post-jailhouse interview on this blog and through one of his contacts, Sam Waksal didn't respond. Given his Manhattan social scene background it should not, perhaps, come as a surprise that the founder of ImClone Systems decided to have his coming-out party in "New York" magazine.

  • Roche Gets Genentech, But At What Price? Monday, 16 Mar 2009 | 12:56 PM ET

    The overwhelming majority of people who have voted in the “Pharma’s Market” poll about the future of Genentech’s execs and top scientists thinks most of them will eventually bolt.

  • I Can’t Get Off Drugs Monday, 16 Mar 2009 | 11:20 AM ET
    pharma_new3.jpg

    Last week was a busy week, to say the least, on the Pharma beat - So I was looking forward to the weekend and escaping all things drug-related. But as fate would have it, it ended up being bookended by references to pharma in a couple of surprising venues.

  • Dendreon Springs Back To Life Friday, 13 Mar 2009 | 1:52 PM ET

    All of a sudden yesterday and today shares of Dendreon  —my favorite biotech story—shot up on heavy volume.

  • Stock Picks Dripping with Cash Friday, 13 Mar 2009 | 11:17 AM ET

    Even when picking stocks, cash is king, according to Wouter Weijand from Fortis Investments, who likes US funeral service company Hillenbrand, Swiss healthcare manufacturer Novartis, and Australia’s ANZ Bank.

  • A Lucky Friday The 13th For Merck Friday, 13 Mar 2009 | 10:48 AM ET

    Shares of Dow component Merck rare getting a nice little shot in the arm this morning on an upgrade by Dr. Tim Anderson at Sanford C. Bernstein. He's putting an "Outperform" or "Buy" rating on MRK and raising his target price three bucks to $30.

  • Just Say Yes to Drugs ... and Drug Stocks! Friday, 13 Mar 2009 | 8:49 AM ET

    Anyone out there who sees hope in the stock market must be on drugs.  And I am: Lipitor and Novasc from Pfizer, Vasotec from Merck, and four other pills, all of which I gobble every day to stop myself from blowing a gasket. So let me say, with some personal pill-popping experience, that this may be a great time to buy drug stocks.

  • Cramer’s Seven Signs This Rally’s Real Thursday, 12 Mar 2009 | 7:32 PM ET

    Even better: Events that could push the Dow up another 1,000 points.

  • Stop Trading!: Billions Change Hands in Pharma Thursday, 12 Mar 2009 | 4:02 PM ET

    Plus, Cramer makes the call on Goldman Sachs, General Electric, Apple, Citigroup and more.

  • Attention Genentech Employees: Heeeeere's Franz! Thursday, 12 Mar 2009 | 3:29 PM ET

    Only on a day like today when it's wall-to-wall Madoff coverage would a $47 billion deal, the second $40-billion-plus deal to be done in four days, struggle to get some airtime.

  • Can Pfizer's Breakthrough Help Steve Jobs? Thursday, 12 Mar 2009 | 11:27 AM ET
    Apple CEO Steve Jobs introduces the new iPod Nano in San Francisco, Tuesday, Sept. 9, 2008.

    When a press release crosses the wires or pops into the inbox from a Dow component announcing positive late-stage test results on a cancer drug, you rush to get the headlines on the air as quickly as possible.

  • Don't Let The Sun Go Down On Biotech Wednesday, 11 Mar 2009 | 11:03 AM ET
    Elton John

    The Biotechnology Industry Organization just announced that Sir Elton will be the keynote speaker at the 2009 BIO International Convention in Atlanta, the superstar's American hometown.

  • The Genentech Roller Coaster Tuesday, 10 Mar 2009 | 3:34 PM ET
    genetech_logo_new.jpg

    On my Thomson Reuters screen I have the stock quotes of a few dozen of the biopharma companies I cover. Lately, when I glance over at it, there's been a lot of red. With today's market rally, there's a whole lotta green. And that's why the quote in red for Genentech kind of sticks out like a sore thumb.

  • Merck's Dick Clark: I Give Him A 41 Tuesday, 10 Mar 2009 | 10:56 AM ET
    Richard Clark, Merck CEO

    They may have the same name, but America's oldest teenager Dick Clark and Merck's Chairman and CEO Dick Clark appear to have little else in common. One loves the camera, the other not so much.

  • Drug Investors Lose Patience Tuesday, 10 Mar 2009 | 10:43 AM ET
    Pharma Stocks

    With cash scarce, credit tight and big drug companies intent on branching into biotechnology themselves, struggling bio-tech start-ups may no longer get second and third chances to succeed from thier investors, the New York Times reports.

  • Are You From Jersey?! Big Pharma's From Jersey! Monday, 9 Mar 2009 | 1:00 PM ET
    New Jersey

    New Jersey, where I live and work, is known as "The World's Medicine Chest" or "The Silicon Valley of Pharma."